HRR - Task

Human Research Roadmap HRP Exploration Data

evidence risks gaps tasks

explore search

- VIIP13
  - VIIP

Ground/Bedrest Drug Countermeasure for VIIP

Task Book: Entry Unavailable
Principal Investigator: TBD

Short Title: Bedrest VIIP Countermeasure

Responsible HRP Element: Human Health Countermeasures

Supporting Org(s):

Funding Status: Unfunded - Task not within current budget

Procurement Mechanism(s):

NASA Research Announcement

Request for Proposals

Request for Information

Aims:
This analog study will evaluate potential drug countermeasures to mitigate the VIIP syndrome.

Integration/Unique Aspects:
None

Resources (Ground Analog)

Ground Analog Resources

Platform	Bedrest
Number of Subjects	12
Can data from subjects be collected over multiple missions/campaigns?	Yes
Fiscal Year	2016
Days per subject	0
Top Level Requirements: TBD

Deliverables (1)

Category: Countermeasures
Subcategory: Prototype Hardware, Pharmaceutical, Nutritional Supplement

Description:
Ground validated pharmacological countermeasure for the VIIP syndrome.

Customer: Space Medicine
Is there a signed Customer-Supplier Agreement? No

Delivery Milestone: 9/28/2018

Mappings

Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Ground/Bedrest Drug Countermeasure for VIIP

Related Tasks (52)

Bracelet Investigation

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Fluid distribution animal study: bone loss, venous pressure, cerebral blood flow, lower limb arteriole atrophy

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Validation of On-Orbit Methodology for the Assessment of Cardiac Function and Changes in the Circulating Volume Using Ultrasound and Braslet-M Occlusion Cuffs, SDTO 17011 U/R

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Hindlimb suspension (HS) as an analog model of ocular alterations associated with cephalad fluid shifts: resveratrol as a countermeasure

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Spaceflight effects on the mouse retina: Histological, gene expression and epigenetic changes after flight on STS-135

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Pilot study to evaluate a novel non-invasive technology to estimate peripheral and central venous pressure

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

rVisual Impairment and Intracranial Pressure Project Data Mining

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Combined effects of gamma radiation and high dietary iron on oxidative damage and antioxidant status in rat eyes

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Phase I: SD-OCT Analysis of The Optic Nerve Head and Surrounding Structures in Long Duration ISS Crew Members Compared to Terrestrial Bound Normals

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Phase II: D-OCT Analysis of The Optic Nerve Head and Surrounding Structures in Long Duration ISS Crew Members Compared to Terrestrial Bound Normals and Pseudotumor/Increased Intracranial Hypertension Patients

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Prospective Observational Study of Ocular Health in ISS Crews

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

A data mining project to identify cardiovascular related factors that may contribute to changes in visual acuity within the astronaut corps

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Risk of visual impairment and intracranial hypertension after space flight: Evaluation of the role of polymorphism of enzymes involved in one-carbon metabolism

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Are Medications Involved in Vision and Intracranial Pressure Changes Seen in Spaceflight?

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Flight-Vascular Function in the Head/Neck

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/On-going VIIP Hardware Techwatch

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/Development of in-flight fundoscopy

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/Fundoscopy Trade Study

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/Development of in-flight diagnostic OCT

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/Diagnostic OCT Trade Study

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

ICP Tech Search (Innocentive, Yet To Come)

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Effects of Microgravity on Intracranial Pressure

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Analysis of a Clinical Database as a Means to Validate Non-invasive Assessment of Intracranial Pressure Using the Cerebral and Cochlear Fluid Pressure (CCFP) Analyzer

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/Upgrade Visual Acuity Software and In-flight Tonometer

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Non-invasive ICP device purchase & evaluation

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Flight validation - Combination Countermeasure for VIIP

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
	VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Ground - Combination Countermeasure for VIIP (Drug + Exercise and/or Mechanical CM)

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
	VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Ground - Aerobic Exercise Countermeasure for VIIIP

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
	VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Drug Countermeasure Flight Validation – Acetazolamide, manipulation of AQP1 and AQP4, Atrial Nateuretic Peptide to decrease ICP, drug to decrease CSF production

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
	VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Head-down tilt as a model for intracranial and intraocular pressures, and retinal changes during spaceflight

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Flight - Contributions of CO2, resistive exercise, and sodium to the VIIP syndrome – effect on cerebrovascular dilation and ICP

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Bedrest – Contributions of CO2, resistive exercise, and sodium to the VIIP syndrome

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Data mining – Contributions of CO2 to the VIIP syndrome

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Pre & Postflight MRV review (central venous congestion)

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Evaluation of increased CSF dynamics (production/absorption) during spaceflight

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Pre and postflight measurement of cerebrospinal fluid (CSF) dynamics (production/absorption)

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Biomarker for identification of increased ICP - Flight Validation

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Biomarker for identification of increased ICP

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Validation of in-flight non-invasive ICP as compared to pre and post lumbar puncture

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Evaluation of spaceflight alterations in neurohumoral control and vascular function changes towards VIIP

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

SD/In-flight monitoring of visual health (MRID)

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Ocular structure, biomechanics and translaminar pressure gradients in relation to the VIIP syndrome

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Data Mining – Ocular structure and biomechanics in relation to the VIIP syndrome

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Visual Impairment Intracranial Pressure Risk: Occupational Surveillance Data Mining

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations Evidence Report

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Microgravity Associated Compartmental Equilibration (MACE)

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
	VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Fluid Distribution before, during and after Prolonged Space Flight

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations
	VIIP13: What are the safe and effective countermeasures (CMs) to mitigate changes in ocular structure and function and intracranial hypertension for spaceflight? (countermeasures)

Human Cerebral Vascular Autoregulation and Venous Outflow in Response to Microgravity-Induced Cephalad Fluid Redistribution

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Distribution of Body Fluids during Long Duration Space Flight and Subsequent Effects on Intraocular Pressure and Vision Disturbance

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Non-Invasive Monitoring of Intracranial Pressure (ICP) with Volumetric Ophthalmic Ultrasound

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Non-invasive ICP Flight Hardware Development

Common Item(s)
	Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations

Print View...

Schedules (1)

This task can be found in the following Risk schedules.

VIIP Schedule

{1}

##LOC[OK]##

{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##

NASA Developer: Jon Shipman NASA Official: Robert Galvez Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact HRP Space Life Sciences Directorate Johnson Space Center USA.gov ExpectMore.gov